Nuclear Medicine Communications

Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > September 2008 - Volume 29 - Issue 9 > Quantitative regional blood flow measurements in exercising...
Nuclear Medicine Communications:
September 2008 - Volume 29 - Issue 9 - pp 770-774
doi: 10.1097/MNM.0b013e328302506e
Original Articles

Quantitative regional blood flow measurements in exercising leg skeletal muscle based on 99mTc-pertechnetate clearance

Seto, Mikito; Bunko, Hisashi; Shuke, Noriyuki; Takahashi, Keisuke; Sakaibori, Youji; Terada, Hitoshi; Imabayashi, Etsuko; Kuji, Ichiei; Matsuda, Hiroshi; Yokoyama, Shigeru

Collapse Box

Abstract

Background and aim: Skeletal muscle blood flow (SMBF) is a crucial indicator of impaired peripheral circulation. Although 133Xe has long been used for estimation of regional SMBF, its lipophilic and volatile nature hampers precise measurement. Therefore, we established an improved method based on 99mTc-pertechnetate ion (99mTcO4-) clearance.

Methods: Ten healthy male volunteers including five rugby players and five non-athletes (each group aged 25-35 years) received injection of 99mTcO4- into the bilateral tibialis anterior muscles and gastrocnemius muscles (GCMs). The radioactivity of 99mTcO4- before, during, and after toe-up or treadmill exercise was traced using a γ-camera. Regional SMBF in absolute values (in ml/min/100 g muscle) was then calculated based on the half-time obtained from the time-activity curve.

Results: In both the groups, SMBF in tibialis anterior muscle changed similarly with values at the same levels. In contrast, SMBF in GCM showed marked difference between the two groups: in rugby players, SMBF in GCM returned to the baseline level (6.5±1.7, n=10) immediately after treadmill exercise, whereas that in non-athletes remained high (16.2±3.2, n=10).

Conclusion: Regional SMBF measured by 99mTcO4- clearance can indicate effectiveness of exercise training, and would be a diagnostic tool and prognostic indicator for use in patients with impaired peripheral circulation.

© 2008 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Article Tools

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.